PL369962A1 - Doustna postać dawki sulfonamidowego przedleku - Google Patents

Doustna postać dawki sulfonamidowego przedleku

Info

Publication number: PL369962A1
Authority: PL; Poland
Prior art keywords: parecoxib; dosage form; oral dosage; sulfonamide; prodrug
Prior art date: 2001-11-13

Application number

PL02369962A

Other languages

English (en)

Inventor

Aziz Karim

Sandeep Nema

Gary D. Ewing

Original Assignee

Pharmacia Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-13

Filing date

2002-11-12

Publication date

2005-05-02

2002-11-12 Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation

2005-05-02 Publication of PL369962A1 publication Critical patent/PL369962A1/pl

Links

239000006186 oral dosage form Substances 0.000 title 1
TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 title 1
229960004662 parecoxib Drugs 0.000 title 1
239000000651 prodrug Substances 0.000 title 1
229940002612 prodrug Drugs 0.000 title 1
229940124530 sulfonamide Drugs 0.000 title 1
150000003456 sulfonamides Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL02369962A 2001-11-13 2002-11-12 Doustna postać dawki sulfonamidowego przedleku PL369962A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US35059601P	2001-11-13	2001-11-13

Publications (1)

Publication Number	Publication Date
PL369962A1 true PL369962A1 (pl)	2005-05-02

Family

ID=23377399

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369962A PL369962A1 (pl)	2001-11-13	2002-11-12	Doustna postać dawki sulfonamidowego przedleku

Country Status (20)

Country	Link
US (1)	US20030100595A1 (pl)
EP (1)	EP1446118B1 (pl)
JP (1)	JP2005509002A (pl)
KR (1)	KR20050044459A (pl)
CN (1)	CN1615135A (pl)
AR (1)	AR037356A1 (pl)
AT (1)	ATE383156T1 (pl)
BR (1)	BR0214081A (pl)
CA (1)	CA2466504A1 (pl)
CO (1)	CO5580744A2 (pl)
DE (1)	DE60224558T2 (pl)
ES (1)	ES2297032T3 (pl)
IL (1)	IL161991A0 (pl)
MX (1)	MXPA04004476A (pl)
NO (1)	NO20042440L (pl)
PL (1)	PL369962A1 (pl)
RU (1)	RU2004114552A (pl)
TW (1)	TW200300680A (pl)
WO (1)	WO2003041705A1 (pl)
ZA (1)	ZA200403328B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7785640B2 (en)	2004-01-16	2010-08-31	Amerilab Technologies, Inc.	Effervescent composition including cranberry extract
SI1799196T1 (sl)	2004-10-08	2016-10-28	Forward Pharma A/S	Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
WO2007038421A2 (en) *	2005-09-27	2007-04-05	University Of Kentucky Research Foundation	Berry preparations and extracts
EP1940382A2 (en) *	2005-10-07	2008-07-09	Aditech Pharma AB	Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
CA2661274A1 (en) *	2006-08-29	2008-03-06	University Of Kentucky Research Foundation	Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de)	2006-09-25	2008-03-26	Losan Pharma GmbH	Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
KR20100099113A (ko) *	2007-10-12	2010-09-10	아스트라제네카 아베	만니톨 및/또는 미세결정질 셀룰로스를 포함하는 지보텐탄 조성물
EP2564839B1 (en)	2009-01-09	2016-05-11	Forward Pharma A/S	Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
JP6102120B2 (ja) *	2012-08-16	2017-03-29	ニプロ株式会社	医薬製剤およびその製造方法
CN104771370B (zh) *	2014-01-14	2020-07-24	南京圣和药业股份有限公司	帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) *	2015-06-11	2016-06-29	成都克莱蒙医药科技有限公司	一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) *	2016-06-21	2018-11-02	马鞍山丰原制药有限公司	一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) *	2020-11-24	2021-02-26	苏州璞正医药有限公司	一种帕瑞昔布衍生物及其制备方法和应用
WO2024208166A1 (zh) *	2023-04-04	2024-10-10	上海汇伦医药股份有限公司	西维来司他用于镇痛的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0729748B1 (en) *	1993-11-18	2003-02-26	Nippon Shinyaku Company, Limited	Process for producing stable medicinal composition
GB9523833D0 (en) *	1995-11-22	1996-01-24	Boots Co Plc	Medical treatment
GEP20032998B (en) *	1996-04-12	2003-06-25	Searle & Co	Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors
SE9703693D0 (sv) *	1997-10-10	1997-10-10	Astra Pharma Prod	Novel combination
WO2001028548A1 (en) *	1999-10-19	2001-04-26	Texas Heart Institute	Treatment of heart disease with cox-2 inhibitors
HRP20010582A2 (en) *	1999-12-08	2002-08-31	Pharmacia Corp	Valdecoxib compositions
KR100717549B1 (ko) *	1999-12-22	2007-05-11	파마시아 코포레이션	시클로옥시게나제-2 억제제의 이중-방출 조성물
US6586474B2 (en) *	2000-03-24	2003-07-01	Pharmacia Corporation	Amidino compounds useful as nitric oxide synthase inhibitors
AR035642A1 (es) *	2000-05-26	2004-06-23	Pharmacia Corp	Uso de una composicion de celecoxib para el alivio rapido del dolor
US6306842B1 (en) *	2000-06-02	2001-10-23	Medinox, Inc.	Protected forms of a combination of pharmacologically active agents and uses therefor
CA2415697A1 (en) *	2000-07-13	2002-01-24	James C. Forbes	Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
PE20021017A1 (es) *	2001-04-03	2002-11-24	Pharmacia Corp	Composicion parenteral reconstituible

2002
- 2002-11-12 MX MXPA04004476A patent/MXPA04004476A/es active IP Right Grant
- 2002-11-12 US US10/292,682 patent/US20030100595A1/en not_active Abandoned
- 2002-11-12 DE DE60224558T patent/DE60224558T2/de not_active Expired - Fee Related
- 2002-11-12 KR KR1020047007335A patent/KR20050044459A/ko not_active Ceased
- 2002-11-12 CA CA002466504A patent/CA2466504A1/en not_active Abandoned
- 2002-11-12 TW TW091133146A patent/TW200300680A/zh unknown
- 2002-11-12 PL PL02369962A patent/PL369962A1/pl not_active Application Discontinuation
- 2002-11-12 IL IL16199102A patent/IL161991A0/xx unknown
- 2002-11-12 BR BR0214081-0A patent/BR0214081A/pt not_active IP Right Cessation
- 2002-11-12 ES ES02789593T patent/ES2297032T3/es not_active Expired - Lifetime
- 2002-11-12 AR ARP020104341A patent/AR037356A1/es unknown
- 2002-11-12 AT AT02789593T patent/ATE383156T1/de not_active IP Right Cessation
- 2002-11-12 WO PCT/US2002/036253 patent/WO2003041705A1/en not_active Ceased
- 2002-11-12 EP EP02789593A patent/EP1446118B1/en not_active Expired - Lifetime
- 2002-11-12 RU RU2004114552/14A patent/RU2004114552A/ru not_active Application Discontinuation
- 2002-11-12 JP JP2003543592A patent/JP2005509002A/ja active Pending
- 2002-11-12 CN CNA028270843A patent/CN1615135A/zh active Pending
2004
- 2004-05-03 ZA ZA200403328A patent/ZA200403328B/en unknown
- 2004-05-07 CO CO04042439A patent/CO5580744A2/es not_active Application Discontinuation
- 2004-06-11 NO NO20042440A patent/NO20042440L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATE383156T1 (de)	2008-01-15
NO20042440L (no)	2004-08-09
US20030100595A1 (en)	2003-05-29
ES2297032T3 (es)	2008-05-01
WO2003041705A1 (en)	2003-05-22
CA2466504A1 (en)	2003-05-22
DE60224558T2 (de)	2009-01-22
RU2004114552A (ru)	2005-02-20
KR20050044459A (ko)	2005-05-12
JP2005509002A (ja)	2005-04-07
IL161991A0 (en)	2005-11-20
EP1446118A1 (en)	2004-08-18
ZA200403328B (en)	2005-04-13
EP1446118B1 (en)	2008-01-09
DE60224558D1 (de)	2008-02-21
TW200300680A (en)	2003-06-16
BR0214081A (pt)	2004-09-28
CN1615135A (zh)	2005-05-11
MXPA04004476A (es)	2004-08-11
CO5580744A2 (es)	2005-11-30
AR037356A1 (es)	2004-11-03

Legal Events

Date	Code	Title	Description
2010-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PL356358A1 (en)	2003-04-07	Solid dosage form of someticone for oral administration
SI1390023T1 (sl)	2008-10-31	Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
AU2002301259A1 (en)	2003-06-12	Simethicone solid oral dosage form
PL364621A1 (pl)	2004-12-13	Doustna postać dawkowania zawierająca nikotynę
EP1407785A4 (en)	2009-12-02	MEDICAL COMPOSITIONS
HUP0400850A3 (en)	2010-10-28	Oral pharmaceutical compositions
IL161991A0 (en)	2005-11-20	Oral dosage form of a sulfonamide prodrug such as parecoxib
AU2003276549A8 (en)	2004-06-15	Pharmaceutical compositions containing a biguanide-glitazone combination
EP1532971A4 (en)	2008-10-08	PREPARATIONS FOR THE ORAL CAVITY
GB2383989B (en)	2004-07-14	Improved oral medicine dispenser
HUP0500638A3 (en)	2008-04-28	Flashmelt oral dosage formulation
GB0126244D0 (en)	2002-01-02	Oral compositions
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð
IL166337A0 (en)	2006-01-16	Oral administration of calctionin
EP1372616A4 (en)	2004-06-23	STABLE PHARMACEUTICAL COMPOSITION BASED ON PRAVASTATIN
GB0016067D0 (en)	2000-08-23	Oral compositions
IL160371A0 (en)	2004-07-25	A new extended release oral dosage form
GB0022297D0 (en)	2000-10-25	Oral compositions
EP1357898A4 (en)	2005-07-13	ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE
AU2003263480A8 (en)	2004-04-19	Oral pharmaceutical compositions of fenofibrate having high bioavailability
AU2002313628A1 (en)	2002-12-03	Tamper resistant oral dosage form
AU2002343538A1 (en)	2003-10-20	Oral delivery of a botanical
IL160372A0 (en)	2004-07-25	A new extended release oral dosage form
AU2002327993A1 (en)	2003-03-10	A new extended release oral dosage form
GB0224762D0 (en)	2002-12-04	Development of a novel strategy for the prevention of dental caries